Home > Insider Trading > Filing (0000904454-13-000490)

Filing Details

Accession Number:: 0000904454-13-000490
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-10 16:49:35
Reporting Period:: 2013-04-08

Filing Date:: 2013-04-10
Accepted Time:: 2013-04-10 16:49:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1333248	Cadence Pharmaceuticals Inc	CADX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1013425	I Jesse Treu	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No
1024000	C James Blair	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	Yes	No	Yes	No
1196863	Nicole Vitullo	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No
1207786	H Brian Dovey	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No
1207789	K Kathleen Schoemaker	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No
1354718	K Brian Halak	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No
1374150	P L Vii Parters Domain	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-04-08	12,217	$6.52	2,407,353	No	4	S	Direct
Common Stock	Disposition	2013-04-09	11,386	$6.71	2,395,967	No	4	S	Direct
Common Stock	Disposition	2013-04-10	1,567	$6.72	2,394,400	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Sold pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person with respect to the Common Stock of the Issuer.
The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
As managing members of Domain Associates, LLC, each Reporting Owner listed below may also be deemed to indirectly beneficially own 27,500 shares of Common Stock held by Domain Associates, LLC.
As managing members of the respective sole general partners of DP VII Associates, L.P., Domain Partners VI, L.P. and DP VI Associates, L.P., each Reporting Owner listed below (except for Brian K. Halak with respect to Domain Partners VI, L.P. and DP VI Associates, L.P.) may also be deemed to indirectly beneficially own the securities of the Issuer held by each such entity as follows: 40,484 shares held by DP VII Associates, L.P., 7,384,819 shares held by Domain Partners VI, L.P. and 78,369 shares held by DP VI Associates, L.P.